9G2.SI SES
Singapore Institute of Advanced Medicine Holdings Ltd.
1W: +0.0%
1M: -6.7%
3M: -3.5%
YTD: -47.2%
1Y: -3.5%
S$0.03 ($0.02)
+0.00 (+0.00%)
Weekly Expected Move ±8.9%
S$0
S$0
S$0
S$0
S$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$16M
-5.6% ▼
4Y CAGR: +5.0%
Gross Profit
$14M
-6.1% ▼
Operating Income
-$22M
-5.2% ▼
Net Income
-$26M
+30.1% ▲
EPS (Diluted)
$-0.02
+30.3% ▲
EBITDA
-$11M
+17.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $13M | $14M | $16M | $17M | $16M |
| YoY Growth | +0.0% | +6.9% | +17.6% | +2.5% | -5.6% |
| Cost of Revenue | $15M | $18M | $19M | $1M | $1M |
| Gross Profit | -$2M | -$4M | -$3M | $15M | $14M |
| Gross Margin | -17.9% | -31.2% | -16.0% | 92.3% | 91.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6M | $9M | $10M | $2M | $2M |
| Operating Expenses | $7M | $10M | $12M | $37M | $37M |
| Operating Income | -$9M | -$15M | -$14M | -$21M | -$22M |
| Operating Margin | -73.3% | -105.1% | -89.0% | -127.6% | -142.3% |
| Interest Expense | $1M | $1M | $2M | $12M | $3M |
| Income Before Tax | -$9M | -$14M | -$19M | -$37M | -$26M |
| Tax Expense | -$38K | -$2M | $0 | $0 | $0 |
| Net Income | -$9M | -$12M | -$18M | -$37M | -$26M |
| Net Margin | -72.4% | -90.0% | -111.3% | -224.9% | -166.5% |
| EPS (Diluted) | $-0.04 | $-0.04 | $-0.06 | $-0.04 | $-0.02 |
| EBITDA | -$3M | -$8M | -$11M | -$13M | -$11M |
| Shares Outstanding | 266M | 323M | 326M | 1.05B | 1.05B |